Multi-omics analysis revealed potential use of immunotherapy and CDK4/6 inhibitors in intimal sarcoma
BackgroundIntimal sarcoma (IS) and angiosarcoma (AS), two rare yet highly aggressive vascular mesenchymal malignancies, present significant therapeutic challenges due to their scarcity, which underscoring the urgent need to investigate genetic alterati…